BKGI fundamentals
BANGKOK GENOMICS INNOVATION PUBLIC financial statements, including revenue, expenses, and profit
The total revenue of BKGI for the last quarter is 95.77 M THB, and it's 9.18% higher compared to the previous quarter. The net income of Q4 24 is 12.31 M THB.
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
0.00
25.00 M
50.00 M
75.00 M
100.00 M
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: THB
Q3 '21
Sep 2021
Q4 '21
Dec 2021
Q1 '22
Mar 2022
Q2 '22
Jun 2022
Q3 '22
Sep 2022
Q4 '22
Dec 2022
Q1 '23
Mar 2023
Q2 '23
Jun 2023
Q3 '23
Sep 2023
Q1 '24
Mar 2024
Q2 '24
Jun 2024
Q3 '24
Sep 2024
Q4 '24
Dec 2024
TTM
Total revenueYoY growth
71.11 M
+37.47%
76.38 M
−16.09%
60.32 M
—
54.12 M
−21.18%
68.32 M
−3.92%
85.78 M
+12.31%
87.72 M
+45.43%
95.77 M
+76.95%
337.59 M
−39.19 M
−35.21 M
−37.51 M
−26.00 M
−38.62 M
−52.66 M
−53.18 M
−58.24 M
−202.70 M
Gross profitYoY growth
31.92 M
+36.62%
41.18 M
−18.00%
22.81 M
—
28.12 M
−20.45%
29.70 M
−6.95%
33.12 M
−19.56%
34.54 M
+51.42%
37.53 M
+33.45%
134.89 M
−20.27 M
−25.57 M
−19.84 M
−21.04 M
−20.17 M
−21.11 M
−23.33 M
−26.09 M
−90.70 M
Operating incomeYoY growth
11.64 M
+64.23%
15.60 M
−45.08%
2.97 M
—
7.08 M
−23.42%
9.53 M
−18.17%
12.02 M
−22.99%
11.21 M
+277.06%
11.44 M
+61.45%
44.19 M
4.68 M
−166.00 K
−209.00 K
13.00 K
114.00 K
1.76 M
3.61 M
1.43 M
6.91 M
Pretax incomeYoY growth
16.32 M
+124.86%
15.44 M
−45.85%
2.76 M
—
7.10 M
−29.73%
9.64 M
−40.93%
13.78 M
−10.72%
14.82 M
+436.07%
12.87 M
+81.28%
51.11 M
−2.14 M
189.00 K
123.00 K
−100.00 K
18.00 K
23.00 K
−420.00 K
−483.08 K
−862.08 K
14.18 M
15.62 M
2.89 M
7.00 M
9.66 M
13.80 M
14.40 M
12.31 M
50.17 M
Net incomeYoY growth
14.18 M
+96.15%
15.62 M
−44.43%
2.89 M
—
7.00 M
−33.69%
9.66 M
−31.87%
13.80 M
−11.66%
14.40 M
+398.68%
12.31 M
+75.93%
50.17 M
14.18 M
15.62 M
2.89 M
7.00 M
9.66 M
13.80 M
14.40 M
12.31 M
50.17 M
Basic earnings per share (Basic EPS)YoY growth
0.02
−47.79%
0.10
−44.45%
0.01
—
0.02
−75.91%
0.02
−12.71%
0.02
−76.43%
0.02
+263.64%
0.02
+28.93%
0.09
Diluted earnings per share (Diluted EPS)YoY growth
0.02
−47.79%
0.10
−44.45%
0.01
—
0.02
−75.91%
0.02
−12.71%
0.02
−76.43%
0.02
+263.64%
0.02
+28.93%
0.09
600.00 M
160.00 M
440.00 M
440.00 M
468.13 M
600.00 M
600.00 M
600.00 M
—
600.00 M
160.00 M
440.00 M
440.00 M
468.13 M
600.00 M
600.00 M
600.00 M
—
EBITDAYoY growth
15.66 M
+67.16%
19.52 M
−38.08%
7.04 M
—
11.11 M
—
13.67 M
−12.71%
16.19 M
−17.05%
15.71 M
+123.28%
16.41 M
+47.70%
61.98 M
EBITYoY growth
11.64 M
+64.23%
15.60 M
−45.08%
2.97 M
—
7.08 M
−23.42%
9.53 M
−18.17%
12.02 M
−22.99%
11.21 M
+277.06%
11.44 M
+61.45%
44.19 M
−59.47 M
−60.78 M
−57.34 M
−47.04 M
−58.79 M
−73.77 M
−76.51 M
−84.33 M
−293.40 M